DM
NUVB icon

Deerfield Management’s Nuvation Bio NUVB Stock Holding History

Deerfield Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,448
Closed -$80K – 152
2025
Q1 		$80K Buy
45,448
+25,282
+125% +$57.5K ﹤0.01% 104
2024
Q4 		$53.6K Buy
+20,166
New +$51.9K ﹤0.01% 101
2024
Q3 		– Sell
-262,205
Closed -$766K – 590
2024
Q2 		$766K Buy
+262,205
New +$800K 0.01% 186
2023
Q3 		– Sell
-5,854,860
Closed -$10.5M – 101
2023
Q2 		$10.5M Hold
5,854,860
– – 0.23% 70
2023
Q1 		$9.72M Hold
5,854,860
– – 0.22% 74
2022
Q4 		$11.2M Buy
5,854,860
+5,609,500
+2,286% +$11.3M 0.23% 71
2022
Q3 		$550K Buy
+245,360
New +$701K 0.01% 112
2022
Q2 		– Sell
-3,577,233
Closed -$18.8M – 132
2022
Q1 		$18.8M Hold
3,577,233
– – 0.42% 52
2021
Q4 		$30.4M Hold
3,577,233
– – 0.64% 45
2021
Q3 		$35.6M Hold
3,577,233
– – 0.69% 42
2021
Q2 		$33.3M Buy
3,577,233
+577,233
+19% +$6.58M 0.59% 55
2021
Q1 		$31.4M Buy
+3,000,000
New +$33.5M 0.66% 49

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management's NUVB Position: Q2 2025 in Review

Deerfield Management sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 45,448 shares — an estimated $80K sold.

Deerfield Management first reported a position in NUVB in Q1 2021 and held it in 12 quarters. The position peaked at $35.6M in Q3 2021. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • Deerfield Management reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • Deerfield Management sold 45,448 Nuvation Bio shares in Q2 2025, an estimated $80K.
  • Deerfield Management first reported a position in Nuvation Bio in Q1 2021 and held it in 12 quarters.
  • Deerfield Management's Nuvation Bio position peaked at $35.6M in Q3 2021.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.